Publications by authors named "Julian Gold"

Claim this Profile
T
The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis.
Gavin Giovannoni, Louisa James, Adekunle A Adeniran, Julian Gold, Lawrence S Young

Brain· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anomaly detection in spatial transcriptomics via spatially localized density comparison.
Gary Hu, Julian Gold, Uthsav Chitra, Sunay Joshi, Benjamin J Raphael

Bioinformatics· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DeST-OT: Alignment of spatiotemporal transcriptomics data.
Peter Halmos, Xinhao Liu, Julian Gold, Feng Chen, Li Ding

Cell Syst· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning Latent Trajectories in Developmental Time Series with Hidden-Markov Optimal Transport.
Peter Halmos, Julian Gold, Xinhao Liu, Benjamin J Raphael

bioRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A count-based model for delineating cell-cell interactions in spatial transcriptomics data.
Hirak Sarkar, Uthsav Chitra, Julian Gold, Benjamin J Raphael

Bioinformatics· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DeST-OT: Alignment of Spatiotemporal Transcriptomics Data.
Peter Halmos, Xinhao Liu, Julian Gold, Feng Chen, Li Ding

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis.
Ruth Dobson, David Holden, Nicola Vickaryous, Jonathan Bestwick, Katila George, Julian Gold

Mult Scler· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of teriflunomide on Epstein-Barr virus shedding in relapsing-remitting multiple sclerosis patients: Outcomes from a real-world pilot cohort study.
Julian Gold, David Holden, John Parratt, Con Yiannikas, Raghib Ahmad

Mult Scler Relat Disord· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is EBV the cause of multiple sclerosis?
Gavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, Michael Levy, E Ann Yeh, Julian Gold

Mult Scler Relat Disord· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia.
Katherine Phan, Ying He, YuHong Fu, Nicolas Dzamko, Surabhi Bhatia, Julian Gold

Commun Med (Lond)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The COVID-19 pandemic and the use of MS disease-modifying therapies.
Gavin Giovannoni, Chris Hawkes, Jeannette Lechner-Scott, Michael Levy, Emmanuelle Waubant, Julian Gold

Mult Scler Relat Disord· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial.
Julian Gold, Dominic B Rowe, Matthew C Kiernan, Steve Vucic, Susan Mathers

Amyotroph Lateral Scler Frontotemporal Degener· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epstein Barr virus shedding in multiple sclerosis: Similar frequencies of EBV in saliva across separate patient cohorts.
David W Holden, Julian Gold, Christopher H Hawkes, Gavin Giovannoni, John M Saxton

Mult Scler Relat Disord· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study.
Julian Gold, Monica Marta, Ute C Meier, Tove Christensen, David Miller

Mult Scler Relat Disord· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Endogenous Retroviruses in Neurological Diseases.
Patrick Küry, Avindra Nath, Alain Créange, Antonina Dolei, Patrice Marche, Julian Gold

Trends Mol Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using eHealth to engage and retain priority populations in the HIV treatment and care cascade in the Asia-Pacific region: a systematic review of literature.
Julianita Purnomo, Katherine Coote, Limin Mao, Ling Fan, Julian Gold

BMC Infect Dis· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prehistoric enemies within: The contribution of human endogenous retroviruses to neurological diseases. Meeting report: "Second International Workshop on Human Endogenous Retroviruses and Disease", Washington DC, March 13th and 14th 2017.
David Kremer, Robert Glanzman, Anthony Traboulsee, Avindra Nath, Laurent Groc, Julian Gold

Mult Scler Relat Disord· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study.
Julian Gold, Raph Goldacre, Hubert Maruszak, Gavin Giovannoni, David Yeates, Michael Goldacre

J Neurol Neurosurg Psychiatry· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Look-back investigation of a health care worker infected with human immunodeficiency virus.
Tai Hing Lam, Dominic Ngai Chong Tsang, Janice Yee Chi Lo, Julian Gold, Hung To Luk

Am J Infect Control· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economics of effective AIDS treatment in Thailand.
Mead Over, Ana Revenga, Emiko Masaki, Wiwat Peerapatanapokin, Julian Gold

AIDS· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Famciclovir or valaciclovir in the management of herpes simplex and varicella zoster infections: an attitudinal survey of clinician perceptions of differential activity.
Don E Smith, Julian Gold

Sex Health· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options.
Mead Over, Elliot Marseille, Kurapati Sudhakar, Julian Gold, Indrani Gupta

Sex Transm Dis· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early clinical experience with atazanavir in treatment-experienced patients.
Sarangapany Jeganathan, Don Smith, Julian Gold

Sex Health· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered lymphocyte heat shock protein 70 expression in patients with HIV disease.
Linda L Agnew, Mark Kelly, Jonathan Howard, Sarangapany Jeganathan, Marijka Batterham, Julian Gold

AIDS· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis